Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

@article{Pereboev2002CoxsackievirusadenovirusRG,
  title={Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells},
  author={Alexander V. Pereboev and Clement K. Asiedu and Yasuhiko Kawakami and Sai Sai Dong and J L Blackwell and Elena A. Kashentseva and Pierre L Triozzi and Wayne A Aldrich and David T. Curiel and Jackie Thomas and Igor P. Dmitriev},
  journal={Gene Therapy},
  year={2002},
  volume={9},
  pages={1189-1193}
}
  • Alexander V. Pereboev, Clement K. Asiedu, +8 authors Igor P. Dmitriev
  • Published 2002
  • Medicine, Biology
  • Gene Therapy
  • A promising approach to immunotherapy involves the loading of dendritic cells (DCs) with genetic material to facilitate sustained expression of a relevant antigen in this population of potent antigen presenting cells (APC). Viral vectors such as adenovirus (Ad) have been used for this purpose. Existing methods for DC infection are limited by lack of specificity and a requirement for DC exposure to high viral doses. Targeting of Ad to DCs with bispecific antibodies has significantly augmented… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 45 CITATIONS, ESTIMATED 58% COVERAGE

    Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells

    VIEW 1 EXCERPT
    CITES METHODS

    CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic.

    VIEW 3 EXCERPTS
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2002
    2020

    CITATION STATISTICS

    • 2 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 21 REFERENCES

    Viral vectors for dendritic cell-based immunotherapy.